Salivary proteomics in biomedical research

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 261-265

  Zhang, Aihua ^a   Sun, Hui ^a   Wang, Ping ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biomarkers; Disease diagnosis; Proteins; Proteomics; Saliva analyses; System biology

Indexed keywords

AMYLASE; AMYLOID A PROTEIN; BETA ACTIN; BIOLOGICAL MARKER; CYTOKERATIN 13; CYTOKERATIN 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPOCORTIN 1; PROTEIN P53; TRANSFERRIN; ZINC FINGER PROTEIN;

AREA UNDER THE CURVE; BREAST CANCER; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; HEAD AND NECK CANCER; HUMAN; MEDICAL RESEARCH; MOUTH SQUAMOUS CELL CARCINOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SALIVA; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CARCINOMA, SQUAMOUS CELL; DIABETES MELLITUS, TYPE 2; HUMANS; MOUTH NEOPLASMS; PROTEOME; PROTEOMICS; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SJOGREN'S SYNDROME;

EID: 84870337731     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.11.001     Document Type: Review

References (53)

1. Schwenk J., Harmel N., Zolles G., et al. Functional proteomics identify cornichon proteins as auxiliary subunits of AMPA receptors. Science 2009, 323(5919):1313-1319.
2. Chu D.S., Liu H., Nix P., et al. Sperm chromatin proteomics identifies evolutionarily conserved fertility factors. Nature 2006, 443(7107):101-105.
3. Ito K., Funayama S., Hitomi Y., et al. Proteome analysis of gelatin-bound salivary proteins in patients with primary Sjögren's syndrome: identification of matrix metalloproteinase-9. Clin Chim Acta 2009, 403(1-2):269-271.
4. Maddalo G., Petrucci F., Iezzi M., et al. Analytical assessment of MALDI-TOF imaging mass spectrometry on thin histological samples. An insight in proteome investigation. Clin Chim Acta 2005, 357(2):210-218.
5. Nozumi M., Togano T., Takahashi-Niki K., et al. Identification of functional marker proteins in the mammalian growth cone. Proc Natl Acad Sci U S A 2009, 106(40):17211-17216.
6. Herr A.E., Hatch A.V., Throckmorton D.J., et al. Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A 2007, 104(13):5268-5273.
7. Zhang A., Sun H., Wang P., Han Y., Wang X. Recent and potential developments of biofluid analyses in metabolomics. J Proteomics 2012, 75(4):1079-1088.
8. Besson D., Pavageau A.H., Valo I., et al. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics 2011, 10(12). [M111.009712].
9. Shelburne S.A., Sumby P., Sitkiewicz I., Granville C., DeLeo F.R., Musser J.M. Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A 2005, 102(44):16037-16042.
10. Lee K., Rho B.S., Pi K., Kim H.J., Choi Y.J. Proteomic analysis of protein expression in Lactobacillus plantarum in response to alkaline stress. J Biotechnol 2011, 153(1-2):1-7.
11. Cohen A.A., Geva-Zatorsky N., Eden E., et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 2008, 322(5907):1511-1516.
12. Tejerizo G.T., Del Papa M.F., Draghi W., et al. First genomic analysis of the broad-host-range Rhizobium sp. LPU83 strain, a member of the low-genetic diversity oregon-like Rhizobium sp. group. J Biotechnol 2011, 155(1):3-10.
13. Charlab R., Valenzuela J.G., Rowton E.D., Ribeiro J.M. Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis. Proc Natl Acad Sci U S A 1999, 96(26):15155-15160.
14. Hust M., Meyer T., Voedisch B., et al. A human scFv antibody generation pipeline for proteome research. J Biotechnol 2011, 152(4):159-170.
15. 2+-activated chloride channel stoichiometrically interacts with an ezrin-radixin-moesin network. Proc Natl Acad Sci U S A 2012, 109(26):10376-10381.
16. Hu S., Jiang J., Wong D.T. Proteomic analysis of saliva: 2D gel electrophoresis, LC-MS/MS, and Western blotting. Methods Mol Biol 2010, 666:31-41.
17. Wang X., Zhang A., Sun H., Wu G., Sun W., Yan G. Network generation enhances interpretation of proteomics data sets by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Analyst 2012, 137(20):4703-4711.
18. Zhang A., Sun H., Wu X., Wang X. Urine metabolomics. Clin Chim Acta 2012, 414C:65-69.
19. Zhang A., Sun H., Han Y., et al. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 2012, 137(18):4200-4208.
20. Wang X., Zhang A., Han Y., et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012, 11(8):370-380.
21. Kumada Y., Zhao C., Ishimura R., Imanaka H., Imamura K., Nakanishi K. Protein-protein interaction analysis using an affinity peptide tag and hydrophilic polystyrene plate. J Biotechnol 2007, 128(2):354-361.
22. Wang W., Sun J., Hollmann R., Zeng A.P., Deckwer W.D. Proteomic characterization of transient expression and secretion of a stress-related metalloprotease in high cell density culture of Bacillus megaterium. J Biotechnol 2006, 126(3):313-324.
23. Forsberg L., Larsson C., Sofiadis A., Lewensohn R., Höög A., Lehtiö J. Pre-fractionation of archival frozen tumours for proteomics applications. J Biotechnol 2006, 126(4):582-586.
24. Will T., Tjallingii W.F., Thönnessen A., van Bel A.J. Molecular sabotage of plant defense by aphid saliva. Proc Natl Acad Sci U S A 2007, 104(25):10536-10541.
25. Zauber H., Mosler S., Heßberg Av, Schulze W.X. Dynamics of salivary proteins and metabolites during extreme endurance sports - a case study. Proteomics 2012, 12(13):2221-2235.
26. Zhang A., Sun H., Wang X. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl Biochem Biotechnol 2012, 10.1007/s12010-012-9891-5.
27. Wu Z., Doondeea J.B., Gholami A.M., et al. Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer. Mol Cell Proteomics 2011, 10(12). [M111.011635].
28. Nagler R., Ben-Izhak O., Cohen-Kaplan V., et al. Heparanase up-regulation in tongue cancer: tissue and saliva analysis. Cancer 2007, 110(12):2732-2739.
29. Epstein J.B., Gorsky M., Guglietta A., Le N., Sonis S.T. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer Dec 1 2000, 89(11):2258-2265.
30. Ruhl S. The scientific exploration of saliva in the post-proteomic era: from database back to basic function. Expert Rev Proteomics 2012, 9(1):85-96.
31. Zhang A., Sun H., Wang X. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 2012, 404(4):1239-1245.
32. Wang X., Zhang A., Sun H. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS 2012, 16(7-8):414-421.
33. Liggett W.S., Barker P.E., Semmes O.J., Cazares L.H. Measurement reproducibility in the early stages of biomarker development. Dis Markers 2004, 20(6):295-307.
34. Bandhakavi S., Stone M.D., Onsongo G., Van Riper S.K., Griffin T.J. A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J Proteome Res 2009, 8(12):5590-5600.
35. Baldini C., Giusti L., Bazzichi L., Lucacchini A., Bombardieri S. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?. Autoimmun Rev 2008, 7(3):185-191.
36. Castagnola M., Cabras T., Vitali A., Sanna M.T., Messana I. Biotechnological implications of the salivary proteome. Trends Biotechnol 2011, 29(8):409-418.
37. Hu S., Yen Y., Ann D., Wong D.T. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery. Drug Discov Today 2007, 12(21-22):911-916. [8].
38. Matta A., Ralhan R., DeSouza L.V., Siu K.W. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery. Mass Spectrom Rev 2010, 29(6):945-961.
39. de Jong E.P., Xie H., Onsongo G., et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One 2010, 5(6):e11148.
40. Ambatipudi K.S., Lu B., Hagen F.K., Melvin J.E., Yates J.R. Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J Proteome Res 2009, 8(11):5093-5102.
41. Xie H., Onsongo G., Popko J., et al. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics 2008, 7(3):486-498.
42. de Jong E.P., van Riper S.K., Koopmeiners J.S., Carlis J.V., Griffin T.J. Sample collection and handling considerations for peptidomic studies in whole saliva; implications for biomarker discovery. Clin Chim Acta 2011, 412(23-24):2284-2288.
43. Jarai T., Maasz G., Burian A., et al. Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma. Pathol Oncol Res 2012, 18(3):623-628.
44. Border M.B., Schwartz S., Carlson J., et al. Exploring salivary proteomes in edentulous patients with type 2 diabetes. Mol Biosyst 2012, 8(4):1304-1310.
45. Rao P.V., Reddy A.P., Lu X., et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 2009, 8(1):239-245.
46. Baldini C., Giusti L., Ciregia F., et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther 2011, 13(6):R194.
47. Jou Y.J., Lin C.D., Lai C.H., et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chim Acta 2010, 681(1-2):41-48.
48. Wu J.Y., Yi C., Chung H.R., et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 2010, 46(4):226-231.
49. Shintani S., Hamakawa H., Ueyama Y., Hatori M., Toyoshima T. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofac Surg 2010, 39(1):68-74.
50. Kooren J.A., Rhodus N.L., Tang C., Jagtap P.D., Horrigan B.J., Griffin T.J. Evaluating the potential of a novel oral lesion exudate collection method coupled with mass spectrometry-based proteomics for oral cancer biomarker discovery. Clin Proteomics 2011, 8:13.
51. Hu S., Arellano M., Boontheung P., et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008, 14(19):6246-6252.
52. Zhang L., Xiao H., Karlan S., et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 2010, 5(12):e15573.
53. Han M.H., Hwang S.I., Roy D.B., et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008, 451(7182):1076-1081.